Rheumatic Bicuspid Aortic Valve Causing Device Embolization during Transcatheter Aortic Valve Replacement| Stephy Publishers
SOJ Cardiology and Current Trends in Surgery - (SOJCCTS)| Stephy Publishers
Abstract
Transcatheter aortic valve replacement (TAVR)
has emerged as a feasible alternative for treatment of severe aortic stenosis
with comparable outcomes to surgical aortic valve replacement (SAVR) in recent
years. We present a case of device embolization in the left ventricular outflow
tract (LVOT) during TAVR in a patient with severe aortic stenosis that required
emergent surgical intervention. During the open-heart surgery for embolized
prosthesis extraction and SAVR, both TEE exam and surgical specimen
demonstrated bicuspid aortic valve and rheumatic nature of the valve with lack
of calcification, which were identified to be the two main factors that contributed
to the complication. In which the insufficient annular calcification increases
the risk of device embolization due to lack of an adequate landing zone for
device anchoring, and the anatomy of bicuspid valve contributes to the
complication due to its associated large annular size and horizontal aorta.
This case highlights device embolization as one possible complication of TAVR
which is associated with substantial morbidity and mortality, the clinical
management process was thoroughly documented with aortic angiography and
transoesophageal echocardiography imaging.
Glossary
Transcatheter aortic valve replacement,
Device embolization, Rheumatic valve, Bicuspid aortic valve
Introduction
The role of transcatheter aortic valve
replacement (TAVR) in the treatment of patients with severe aortic stenosis
(AS) has evolved since its first FDA approval in 2012. The landmark series of
Placement of Aortic Transcatheter Valve (PARTNER) trials reflected robust
evidence for TAVR in high, intermediate, and low risk patients. Moreover,
technologic improvements and procedure simplification have contributed to
increased volume of TAVRs. Complications of TAVR include access site or aortic
vascular injury such as dissection, stenosis, perforation, rupture, and
aneurysm. Other procedure related complications are associated with device
landing zone which include aortic annular rupture, left ventricular
perforation, cardiac tamponade, and device embolization. Conduction
disturbances, stroke, paravalvular leak, and coronary obstruction can also
occur after TAVR. Around 1% of patients undergoing TAVR require surgical
bailout with the most common reasons being valve dislodgement (22%),
ventricular rupture (19.9%) and rupture of the aortic valve (14.2%).1 Valve
embolization is an infrequent event with an incidence of 0.2% to 1.7% and
accounts for about 45% of emergency cardiac surgery in patients treated with
TAVR.1 We present the case of a patient undergoing TAVR complicated by device
embolization in the left ventricular outflow tract (LVOT) requiring emergent
surgical intervention.
Case Presentation
A 50-year-old male with a past medical
history of essential hypertension, paroxysmal atrial fibrillation, and cerebral
vascular disease presented to our institution with palpitations, substernal
chest pain and worsening shortness of breath. He was diagnosed with severe AS
and evaluated by cardiothoracic surgery for surgical aortic valve replacement
(SAVR). His predicted operative morbidity or mortality of surgical aortic valve
replacement based on the Society for Thoracic Surgeons database (STS score) was
calculated to be 1.4% (low risk), however, he rejected surgical intervention
thus TAVR was planned. A comprehensive workup was performed including
transthoracic echocardiography (TTE) which revealed a left ventricular ejection
fraction (LVEF) of 35%, mildly dilated ascending aorta, and severe aortic valve
stenosis with the following measurements: LVOT 2.0cm, annulus 2.5cm, V1 of 0.8,
V2 of 3.9m/s, MG 40mmHg, AVA 0.8cm2, and no aortic regurgitation (AR). However,
the aortic valve morphology was unclear and appeared to be congenital bicuspid
or unicuspid on TTE. Computed tomographic (CT) evaluation of the heart revealed
a tricuspid aortic valve with a hypo plastic right cusp and severe aortic valve
calcification. Coronary angiogram revealed normal coronary arteries. All
studies were reviewed by the multidisciplinary heart team and the decision was
made to proceed with transfemoral TAVR.
To read more #Cardiology #Surgery
https://www.stephypublishers.com/sojccts/fulltext/SOJCCTS.MS.ID.000504.php
#Openaccessjournals
https://www.stephypublishers.com/
Comments
Post a Comment